Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
| Brand name | ALYACEN 1/35 |
| Generic name | NORETHINDRONE AND ETHINYL ESTRADIOL |
| Distributed by / for | Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430 |
| NDC | 68462-556-29 |
| Full product label | Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29 |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
| Distribution | USA Nationwide. |
| Recall initiated | 2026-05-27 |
| Report date | 2026-06-24 |
| Recall completed | — |
| Recall number | D-0588-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Elmwood Park NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗